Akanda Corp.

Akanda Corp.

Akanda Corp. listed on Nasdaq in March 2022 following a business combination that gave it control of Bophelo, a Lesotho-based cultivation campus that had previously been a supplier to Canopy Growth. The firm was founded in 2018 and maintains its corporate headquarters in London. Chairperson Louisa Mojela, a prominent South African businesswoman and former head of the Wiphold investment group, anchored the early Bophelo project and has chaired Akanda through its post-merger restructuring. The firm's Lesotho campus sits at roughly 1,600 meters elevation in the Mafeteng district, a highland position that provides natural ultraviolet light and a temperate climate that reduces indoor energy costs against Canadian benchmarks. The operating strategy rests on producing low-cost, high-potency medical cannabis flower, extracts, and distillates for European and select non-European markets. The Bophelo facility operates under GACP certification and has pursued EU-GMP qualification for its processing wing, which Akanda views as the licensing gate for exporting into Germany — the firm's primary target market. In addition to wholesale flower and extract, the firm has explored finished branded products, including a proprietary THC formulation called CanMart. Deployment remains heavily concentrated in the Lesotho asset, with past operational experiments in Portugal and the United Kingdom sidelined through 2023 divestitures. Akanda does not run a Canadian indoor facility, differentiating its cost structure from most of its small-cap cannabis peers. Akanda's operational scale reflects its micro-cap listing size. The firm has not disclosed total professional headcount, but its public filings and leadership structure suggest a lean executive group split between London and Lesotho. In the second half of 2024, the company appointed Katie Field as Interim CEO, replacing Tej Virk, who departed in early 2024 (per the firm, 2024). Field had previously served on Akanda's board as a non-executive director. The firm uses a traditional corporate board-and-officer structure rather than a single-family governance model, and its capital base is predominantly US retail and institutional shareholders who bought into the NASDAQ listing. No adjacent philanthropic or operating-company vehicles have been disclosed. Akanda's structural differentiator — and the central risk allocators weigh — is its jurisdictional bet. As a NASDAQ-listed cannabis company with its producing asset wholly inside Lesotho, the firm combines US equity-market capital-raising with an African cultivating and export platform. That architecture bypasses the federal prohibition that bars US cannabis companies from accessing major US exchanges. Yet it also exposes Akanda to Lesotho-specific infrastructure risk, regulatory shifts in European importing authorities, and the liquidity constraints of a sub-$10 million market cap. For a professional allocator, Akanda is less a family office than a publicly traded real-asset-and-license vehicle attempting to arbitrage the spread between African production costs and European wholesale cannabis prices.